SYRE
Spyre Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$39.89
-0.52 ▼ -1.29%
🌙 3월 13일 7:52 PM ET (한국 3/14 08:52)
$40.15
+0.26 ▲ +0.65%
| Index | RUT | P/E | - | EPS (ttm) | -2.08 | Insider Own | 18.14% | Shs Outstand | 0.08B | Perf Week | -0.65% |
| Market Cap | 3.13B | Forward P/E | - | EPS next Y | -7.15% | Insider Trans | -0.75% | Shs Float | 0.06B | Perf Month | 17.6% |
| Enterprise Value | 2.53B | PEG | - | EPS next Q | -0.67 | Inst Own | 92.49% | Short Float | 15.53% | Perf Quarter | 15.09% |
| Income | -0.14B | P/S | - | EPS this Y | -47.36% | Inst Trans | 28.71% | Short Ratio | 13.82 | Perf Half Y | 146.23% |
| Sales | 0.00B | P/B | 5.58 | EPS next 5Y | -18.75% | ROA | -19.59% | Short Interest | 9.99M | Perf YTD | 21.76% |
| Book/sh | 7.15 | P/C | 4.14 | EPS past 3/5Y | 57.01% 44.61% | ROE | -22.03% | 52W High | -12.83% ($45.76) | Perf Year | 121.24% |
| Cash/sh | 9.63 | P/FCF | - | Sales past 3/5Y | - | ROIC | -18.99% | 52W Low | 265.63% ($10.91) | Perf 3Y | 331.24% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 34.23% | Gross Margin | - | Volatility(W/M) | 5.55% 5.89% | Perf 5Y | -79.93% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | -100% | Oper. Margin | - | ATR (14) | 2.25 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 13.25 | EPS Q/Q | 12.65% | Profit Margin | - | RSI (14) | 53.14 | Recom | 1.07 |
| Dividend Gr. 3/5Y | - | Current Ratio | 13.25 | Sales Q/Q | - | SMA20 | -2.3% ($40.83) | Beta | 3.1 | Target Price | $58.57 |
| Payout | - | Debt/Eq | 0 | Earnings | 2000000 | SMA50 | 11.02% ($35.93) | Rel Volume | 1.17 | Prev Close | $40.41 |
| Employees | 102 | LT Debt/Eq | 0 | EPS/Sales Surpr. | 1.3% - | SMA200 | 64.47% ($24.25) | Avg Volume(3M) | 0.72M | Price | $39.89 |
| IPO | 2016/4/7 | Option/Short | Yes/Yes | Trades | 22202 | Volume | 844,900 | Change | -1.29% |
뉴스 로딩 중...